Free Trial
NASDAQ:DRIO

DarioHealth (DRIO) Stock Price, News & Analysis

DarioHealth logo
$0.52 -0.03 (-5.09%)
As of 03:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About DarioHealth Stock (NASDAQ:DRIO)

Key Stats

Today's Range
$0.52
$0.57
50-Day Range
$0.43
$0.72
52-Week Range
$0.38
$1.55
Volume
355,326 shs
Average Volume
405,671 shs
Market Capitalization
$23.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Moderate Buy

Company Overview

DarioHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

DRIO MarketRank™: 

DarioHealth scored higher than 27% of companies evaluated by MarketBeat, and ranked 830th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DarioHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    DarioHealth has received no research coverage in the past 90 days.

  • Read more about DarioHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for DarioHealth are expected to grow in the coming year, from ($1.18) to ($1.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DarioHealth is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DarioHealth is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DarioHealth has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about DarioHealth's valuation and earnings.
  • Percentage of Shares Shorted

    7.52% of the float of DarioHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    DarioHealth has a short interest ratio ("days to cover") of 19.2, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in DarioHealth has recently increased by 2.70%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    DarioHealth does not currently pay a dividend.

  • Dividend Growth

    DarioHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.52% of the float of DarioHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    DarioHealth has a short interest ratio ("days to cover") of 19.2, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in DarioHealth has recently increased by 2.70%, indicating that investor sentiment is decreasing.
  • News Sentiment

    DarioHealth has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for DarioHealth this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for DRIO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DarioHealth insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.20% of the stock of DarioHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 33.39% of the stock of DarioHealth is held by institutions.

  • Read more about DarioHealth's insider trading history.
Receive DRIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter.

DRIO Stock News Headlines

DarioHealth Announces 20-to-1 Reverse Stock Split
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
DarioHealth Corp. (DRIO) Q2 2025 Earnings Call Transcript
See More Headlines

DRIO Stock Analysis - Frequently Asked Questions

DarioHealth's stock was trading at $0.7861 at the start of the year. Since then, DRIO shares have decreased by 28.4% and is now trading at $0.5630.

DarioHealth Corp. (NASDAQ:DRIO) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.07. The firm earned $6.75 million during the quarter, compared to the consensus estimate of $7.48 million. DarioHealth had a negative net margin of 162.73% and a negative trailing twelve-month return on equity of 65.89%.
Read the conference call transcript
.

Shares of DarioHealth reverse split on the morning of Thursday, August 28th 2025.The 1-20 reverse split was announced on Monday, August 25th 2025. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, August 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

DarioHealth subsidiaries include these companies: PsyInnovations Inc., Upright Technologies Ltd., Labstyle Innovation Ltd., PsyInnovations India Private Limited., and Upright Technologies Inc..

DarioHealth's top institutional investors include AMH Equity Ltd (0.47%) and XTX Topco Ltd (0.14%). Insiders that own company stock include Erez Raphael and Steven Charles Nelson.
View institutional ownership trends
.

Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DarioHealth investors own include NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Tesla (TSLA).

Company Calendar

Last Earnings
5/14/2025
Today
8/26/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:DRIO
CIK
1533998
Employees
200
Year Founded
2011

Price Target and Rating

High Price Target
$3.00
Low Price Target
$1.00
Potential Upside/Downside
+263.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.66)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$42.75 million
Net Margins
-162.73%
Pretax Margin
-162.13%
Return on Equity
-65.89%
Return on Assets
-39.03%

Debt

Debt-to-Equity Ratio
0.48
Current Ratio
3.30
Quick Ratio
2.83

Sales & Book Value

Annual Sales
$27.04 million
Price / Sales
0.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.11 per share
Price / Book
0.26

Miscellaneous

Outstanding Shares
45,500,000
Free Float
40,401,000
Market Cap
$25.03 million
Optionable
Optionable
Beta
1.24

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:DRIO) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners